[3] It aims to detect HCM early, so that interventions can be commenced to prevent complications and sudden cardiac death.

[2] It aims to detect HCM early, so that interventions can be commenced to prevent complications and sudden cardiac death.

Screening and therefore diagnosing at an early age allows a patient to receive the appropriate therapies (medication for symptoms, ICD implantation, or myectomy) which in turn will improve the quality and length of life.

Without appropriate therapies, the progression of familial HCM during childhood can lead to increased complications at an earlier stage of life.

[4] The American Heart Association have developed a 14-point evaluation for competitive athletes, which it recommends for screening healthy teenagers and young adults.

[3] Limited literature on screening Arab and African male athletes shows a high false positive rate; that is the tests indicate they have the disease when they don't.

[9] HCM has traditionally been of greater interest in Europe, North America, Japan, Israel, and Australia.